Clinical Trials Directory

Trials / Unknown

UnknownNCT02123784

Biomarkers for the Surgical Treatment of Rotator Cuff Tears

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Balgrist University Hospital · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Identification of biomarkers that can predict the outcome of the surgical treatment (i.e. the rate of re-rupture) of tears in the rotator cuff tendon.

Detailed description

Rotator cuff tears (i.e. structural failure and tissue disruption in at least one of the four muscles and tendons that form the rotator cuff) are extremely common injuries and represent the most common muscle-tendon tear in patients. Repair of rotator cuff tears is usually advocated for painful tears with functional impairment. However, high failure rates of 13-68% have been reported for surgical repair of rotator cuff tears, irrespective of the surgical technique employed. Higher rates of re-rupture are associated with larger tears, increased patient age, and increased fatty degeneration of the cuff muscles. There is no general consensus as to the causes of re-rupture; where mechanical factors, the existing techniques of suturing, and biological factors are considered as the main factors of recurrence.

Conditions

Timeline

Start date
2014-04-01
Primary completion
2017-06-01
Completion
2017-12-01
First posted
2014-04-28
Last updated
2016-07-04

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02123784. Inclusion in this directory is not an endorsement.

Biomarkers for the Surgical Treatment of Rotator Cuff Tears (NCT02123784) · Clinical Trials Directory